Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Asset Writedowns and Impairment came in at $78000.0 in Q3 2025, down 74.59% year-on-year from $307000.0 in Q3 2024, and up 252.94% on a QoQ basis from -$51000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 9 years of Asset Writedowns and Impairment data on file, last reported at $78000.0 in Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 74.59% year-over-year to $78000.0 in Q3 2025; TTM through Sep 2025 was $358000.0, a 45.26% decrease from a year earlier, with the FY2024 full-year figure at $485000.0, up 35.85% from the prior year.
- Asset Writedowns and Impairment for Q3 2025 stood at $78000.0, up from -$51000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for XTNT reached as high as $864000.0 in Q4 2021 and fell as low as -$210000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $204736.8 across 5 years, with a median of $129000.0 in 2024.
- Across the five-year window, Asset Writedowns and Impairment surged 7754.55% in 2021 and sank 412.2% in 2024, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $864000.0 in 2021, then tumbled by 71.76% to $244000.0 in 2022, then sank by 116.8% to -$41000.0 in 2023, then sank by 412.2% to -$210000.0 in 2024, then surged by 137.14% to $78000.0 in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $78000.0 in Q3 2025, -$51000.0 in Q2 2025, and $541000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Xtant Medical Holdings | 62.02 Mn | 44.69 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Sep 30, 2024 | 307,000.00 |
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |